← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksWSTDividend History
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets

WST logoWest Pharmaceutical Services, Inc. (WST) Dividend History

Income profile from 1987 to 2026 with payout safety and yield-on-cost trend

Trailing Dividend / Share
$0.84
4 payments in last 12 months
Dividend Yield
0.3%
Current annualized yield
Payout Ratio
12.4%
Sustainable
Dividend Streak
33 years
Consecutive annual increases
5Y Dividend CAGR5.5%
Current Yield on Cost0.3%
Yield on Cost Trendflat

WST Dividend Income Check

Safety

12.4% payout ratio with sustainable safety profile.

Consistency

33 straight years of dividend increases.

Income Trend

Yield on cost is 0.3% and trend is flat.

WST Dividend Scorecard

Dividend Aristocrat33Y streak

Yield & Income

Dividend Yield0.3%
Trailing DPS$0.84
FrequencySemi-Annual
Payments / 12M4

Payout Safety

Earnings Payout12.4%
Earnings SafetySustainable
FCF Payout13.2%
FCF SafetyWell Covered
Piotroski F-Score6/9

Growth

Growth Streak33 years
3Y CAGR5.2%
5Y CAGR5.5%
Yield on Cost (5Y)0.3%
YOC Trendflat

Total Returns

Buyback Yield0.6%
Total Shareholder Yield0.9%
1Y Total Return52.6%
5Y Total Return-3.9%
Div Contribution (5Y)1.2%
Estimated $10K growth (return + dividends):
5Y ago$9,60810Y ago$45,38320Y ago$174,852

Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.

WST Income Growth Story

Dividend per share and yield on cost over time (40 years of payments)

WST Dividend Safety Story

EPS is the container — dividend is what's drawn out

Dividend Analysis

Dividend Aristocrat

Payout Safety

West Pharmaceutical Services, Inc. distributes 12.4% of earnings as dividends (Sustainable). When measured against free cash flow—a stricter test—the payout ratio stands at 13.2%, rated "Well Covered".

Piotroski F-Score: 6/9 — moderate financial health.

Growth Track Record

WST has raised its dividend for 33 consecutive years, with a 3-year CAGR of 5.2% and 5-year CAGR of 5.5%.

Total Shareholder Returns

Beyond cash dividends, WST returns capital through share repurchases. The combined picture: 0.3% dividend yield, 0.6% buyback yield, 0.9% total shareholder yield.

Income Trend & Total Return

Yield on cost (5-year basis) has reached 0.3% and is currently flat. The 5-year total return is -3.9%, with dividends contributing 1.2% of that performance.

DRIP Growth

A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $45,383 today.

WST Recent Dividend Payments

Last 20 payments · Semi-Annual

TTM Total$3.95
Avg/Payment$0.1975
Ex-DateAmountChangeYield %Payment DateDeclaration DateRecord DateFrequency
Apr 29, 2026Latest$0.2200—29.46%May 6, 2026Feb 16, 2026Apr 29, 2026Quarterly
Jan 28, 2026$0.2200—36.46%Feb 4, 2026Dec 9, 2025Jan 28, 2026Quarterly
Nov 12, 2025$0.2200↑ +4.8%31.04%Nov 19, 2025Jul 23, 2025Nov 12, 2025Quarterly
Jul 30, 2025$0.2100—33.71%Aug 6, 2025Apr 24, 2025Jul 30, 2025Quarterly
Apr 30, 2025$0.2100—39.28%May 7, 2025Feb 20, 2025Apr 30, 2025Quarterly
Feb 7, 2025$0.2100—25.50%Feb 11, 2025Jan 28, 2025Feb 7, 2025Quarterly
Nov 13, 2024$0.2100↑ +5.0%23.55%Nov 20, 2024Oct 24, 2024Nov 13, 2024Quarterly
Jul 31, 2024$0.2000—26.13%Aug 7, 2024Apr 25, 2024Jul 31, 2024Quarterly

WST Dividend vs Peers

Comparable companies in the same industry

#8 yield in peer group
Div Yield
0.3%
#8 of 8
Safety
Sustainable
12.4% payout
Streak
33Y
5.5% 5Y CAGR
Total Shareholder
0.9%
#7 of 8
CompanyMkt CapYieldPayoutFCF PayoutStreak5Y GrowthBuybackTSY1Y ReturnSafety
WST logoWSTWest Pharmaceutical …
$22.5B0.3%12.4%13.2%335.5%0.6%0.9%52.6%Sustainable
ATR logoATRAptarGroup, Inc.
$7.9B1.5%30.8%38.9%335.4%4.6%6.1%-17.5%Sustainable
GTLS logoGTLSChart Industries, In…
$9.9B0.3%—14.2%1—0.0%0.3%37.4%Unknown
1st
AMCR logoAMCRAmcor plc
$18.6B6.6%1.7%151.3%112.2%0.7%7.3%366.1%Sustainable
SEE logoSEESealed Air Corporati…
$6.2B1.9%23.6%26.0%04.7%0.0%1.9%48.4%Sustainable
2nd
PFE logoPFEPfizer Inc.
$150.8B6.5%1.3%107.7%152.8%0.0%6.5%23.4%Sustainable
JNJ logoJNJJohnson & Johnson
$541.3B2.2%84.1%59.1%365.7%0.4%2.6%48.8%Watch
3rd
MRK logoMRKMerck & Co., Inc.
$280.5B2.9%44.8%65.2%145.9%1.8%4.7%47.9%Sustainable

WST Annual Dividend History (1987–2026)

40 years of dividend data

GrowthDecline
YearDPSYoYPmtsEPSPayoutCoverageFCF/ShareFCF PayoutBuyback YldTotal Shld YldYOC
2026YTD$0.44—2———————0.2%
2025$0.854.9%4$6.8012.5%8.00x$6.4513.2%0.7%1.0%0.3%
2024$0.815.2%4$6.6912.1%8.26x$3.7521.6%2.3%2.6%0.3%
2023$0.775.5%4$7.889.8%10.23x$5.5014.0%1.7%1.9%0.3%
2022$0.735.8%4$7.739.4%10.59x$5.8012.6%1.2%1.5%0.3%
2021$0.696.2%4$8.678.0%12.57x$4.3315.9%0.4%0.6%0.2%
2020$0.656.6%4$4.5714.2%7.03x$3.9316.5%0.6%0.8%0.2%
2019$0.617.0%4$3.2119.0%5.26x$3.1919.1%0.8%1.2%0.2%
2018$0.577.5%4$2.7420.8%4.81x$2.4423.4%1.0%1.5%0.2%
2017$0.538.2%4$1.9926.6%3.75x$1.7530.3%1.0%1.5%0.2%

Full WST Stock Analysis

Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.

View Analysis

See WST's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is WST Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare WST vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

WST — Frequently Asked Questions

Quick answers to the most common questions about buying WST stock.

How much dividend does WST pay per share?

West Pharmaceutical Services, Inc. (WST) pays a trailing 12-month dividend of $0.84 per share, with a current dividend yield of +0.3%. Payments are made Semi-Annual.

When is WST's next ex-dividend date?

WST's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. WST typically pays dividends Semi-Annual.

Is WST's dividend safe?

WST's dividend safety is rated "Sustainable" based on an earnings payout ratio of +12.4% and FCF payout ratio of +13.2%. With 33 consecutive years of dividend growth, the track record supports sustainability.

Is WST a Dividend Aristocrat?

Yes, West Pharmaceutical Services, Inc. is classified as a Dividend Aristocrat with 33 consecutive years of dividend increases. The 5-year dividend CAGR is +5.5%, demonstrating above-inflation dividend growth.

How often does WST pay dividends?

West Pharmaceutical Services, Inc. pays dividends Semi-Annual. The trailing 12-month total is $0.84 per share. Dividend data on this page covers 39+ years from 1987 to 2026.

How much would $10,000 invested in WST grow with dividend reinvestment?

With dividends reinvested (DRIP), $10,000 invested in WST five years ago would be worth approximately $9,608 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.

What is WST's yield on cost for long-term holders?

WST's yield on cost — the current dividend divided by the original purchase price — is +0.3% for a 5-year holding period. This means long-term holders earn a higher effective yield than today's +0.3% market yield, thanks to consistent dividend growth.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.